The WOCN Society 40th Annual Conference (June 21-25th, 2008)


2224

The successful use of a new adjunct therapy in a both acute and chronic wounds – a prospective, descriptive case series

Susan Hill, RN, BSN, CWOCN, Carole Dalbey, RN, BSN, and Christine Davis, MD, CWS. Banner Baywood Medical Center and Banner Baywood Heart Hospital, Director of WOC Department, 6644 East Baywood Avenue, Mesa, AZ 85206

Wound healing involves a complex series of events, which include cell division, neovascualrization and the synthesis of new extracellular matrix (ECM) components. In acute wound, there are four overlapping well defined phases of hemostasis, inflammation, proliferation and remodeling. Physiological events in a chronic wound do follow this traditional model of wound repair, Enoch (2003). They appear as being “stuck” in the inflammation phase.

 

Collagen, which is produced by fibroblasts, is the most abundant protein in the body. As a natural structural protein, collagen is involved in all three phases of the wound healing cascade. Fleck (2007). It stimulates cellular migration and contributes to new tissue development.

 

The aim of this poster presentation is to illustrate that collagen has a beneficial effect, as an adjunct therapy, in both acute and chronic wounds. Three cases will be presented including surgical, traumatic and chronic wounds. All wounds have responded positively to the new collagen wound matrix dressing* as an adjunct therapy and have demonstrated a reduction in wound size. The dressing has been well tolerated by all patients. A pictorial and graphical representation of the reduction in wound size will be presented for all cases.

 

The benefits of collagen acing a sacrificial substrate in chronic wounds will be discussed, together with its obvious benefits as a matrix during the proliferative phase of acute wound healing.

 

* BIOSTEP Ag – Collagen Matrix Dressing with Silver. Smith & Nephew Wound Management Inc, Largo, Fl.